MITF and cancer: The discriminant isoforms in the invasive phenotype (MITF–) were enriched for multiple cancer hallmarks, whereas the proliferative phenotype (MITF+) presented enrichment only for activation of KRAS signaling, which does not appear in the invasive phenotype (Additional file 2: Figure S5b).